Radient Technologies Inc. Completes Second Tranche of Private Placement Offering

/NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES/

EDMONTON, Jan. 26, 2015 /CNW/ - Radient Technologies Inc. ("Radient" or the "Corporation") (TSX Venture: RTI) announces that it has completed the second tranche of its non-brokered private placement (the "Offering") of units of the Corporation (the "Units") previously announced on December 12, 2014. Under the second tranche of the Offering, the Corporation issued and sold 1,800,000 Units for aggregate gross proceeds of $180,000.  Each Unit is comprised of one common share of the Corporation (a "Common Share") and one half Common Share purchase warrant (each whole warrant, a "Warrant"), with each whole Warrant entitling the holder to subscribe for one additional Common Share at a price of $0.50 per Common Share until the date that is 42 months from the date of issuance of such Warrant. 

A portion of the second tranche of the Offering constitutes a "related party transaction" under Multilateral Instrument 61-101 ("MI 61-101") as Denis Taschuk, a director and senior officer of the Corporation, purchased 250,000 Units.  Prior to completion of the second tranche of the Offering, Mr. Taschuk owned or controlled 194,812 Common Shares or approximately 0.52% of the total Common Shares issued and outstanding.  After giving effect to the second tranche of the Offering, and assuming Mr. Taschuk exercises all of the Warrants underlying the Units, Mr. Taschuk would own or control 569,812 Common Shares or approximately1.4% of the issued and outstanding Common Shares.  The Offering is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101, as neither the fair market value of securities being issued to insiders nor the consideration being paid by insiders will exceed 25% of the Corporation's market capitalization.  The Corporation did not file a material change report 21 days prior to the closing of the second tranche of the Offering as the details of the participation of the related party of the Corporation had not been confirmed at that time.

On the completion of the second tranche of the Offering, the Corporation paid a finder's fee comprised of a cash commission of $400 and 4,000 finder Common Share purchase warrants (the "Finder Warrants").  Each Finder Warrant is exercisable for one Common Share at a price of $0.10 per Common Share until the date that is 24 months from date of issuance of such Finder Warrant.  All securities issued in connection with the Offering are subject to a statutory four-month hold period. The Corporation is expected to close additional tranches of the Offering, subject to the receipt of all necessary approvals, including the approval of the TSX Venture Exchange.

About Radient
Radient extracts natural compounds from a range of biological materials using microwave assisted processing ("MAP™"), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its 20,000 square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health, personal care and biofuel markets. Visit www.radientinc.com for more information.

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Corporation cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Corporation's control. Such factors include, among other things: risks and uncertainties relating to the Corporation's ability to complete the proposed Offering. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, the Corporation undertakes no obligation to publicly update or revise forward-looking information.

This news release shall not constitute an offer to sell or the solicitation of any offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The shares offered will not be and have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Radient Technologies Inc.